A Study to Evaluate the Incrediwear Products Immediately After ACL Repair
Launched by TEXAS BONE AND JOINT · Oct 30, 2024
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
After knee surgery, the participant will be randomly assigned to one of the three groups. The participant will have a 1-in-3 chance of being assigned to each group. The products will be placed on the participant by the hospital staff according to the random assignment sent with the surgical packet.
Study Screening/pre-operative appointment
* The surgeon confirms the participant meets the inclusion criteria and are scheduled for surgery in the next few weeks, and how the participant may be eligible to participate in the study.
* The surgeon will discuss the study and possible risks/benefit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consented to protocol
- • Compliant protocol
- • BMI less than 35
- • Undergoing ACL or ACL+MCL within 30 days
- Exclusion Criteria:
- • Pregnancy
- • Rheumatoid Arthritis
- • Poorly controlled diabetes (HgA1c \> 7.5)
- • Previous blood clots
- • BMI greater than 35
- • Varicosities on operative leg
- • Pain management patient
- • Prior knee surgery to the operative / study knee
- • Worker's Comp patients
About Texas Bone And Joint
Texas Bone and Joint is a leading clinical trial sponsor specializing in orthopedic research and development. Committed to advancing musculoskeletal health, the organization conducts innovative clinical trials aimed at evaluating new treatments and technologies for bone and joint disorders. With a dedicated team of experienced researchers and healthcare professionals, Texas Bone and Joint emphasizes rigorous scientific methodology and patient-centered care, ensuring that their studies adhere to the highest ethical standards while contributing valuable insights to the field of orthopedics. Their mission is to improve patient outcomes through cutting-edge research and collaboration with industry partners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denton, Texas, United States
Patients applied
Trial Officials
Christopher Flowers, MD, MS
Principal Investigator
Texas Bone and Joint
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported